6 investors discuss why AI is more than just a buzzword in biotech
TechCrunch
DECEMBER 15, 2022
. “Most of the companies we have seen have an AI component to support the discovery or development processes,” Francisco Dopazo, a general partner at Humboldt Fund told TechCrunch recently. The survey also covers the implications of U.S IBM sold Watson Health to private equity in 2022 after investing billions into it.
Let's personalize your content